东星医疗(301290.SZ):预计2025年净亏损3200万元-4500万元

Core Viewpoint - Dongxing Medical (301290.SZ) expects a net profit attributable to shareholders of the listed company to be between -45 million and -32 million yuan for 2025, indicating a challenging financial outlook due to increased market competition and a slowdown in customer demand [1] Financial Performance - The company's revenue from stapler components and medical equipment has declined, leading to a decrease in overall gross profit compared to the same period last year [1] - The expected net profit after deducting non-recurring gains and losses is projected to be between -72 million and -51 million yuan for 2025 [1] Asset Impairment - Based on the prudence principle and an analysis of the operating performance and profitability of its wholly-owned subsidiary, Jiangsu Zihang Precision Hardware Co., Ltd., the company is conducting an impairment test on its asset group as of December 31, 2025 [1] - The preliminary estimate indicates that the company will recognize goodwill impairment of approximately 97.91 million yuan and intangible asset impairment of about 5.63 million yuan, totaling an impairment provision of approximately 103.54 million yuan [1] - The impact of the impairment provision on the company's net profit has been considered in the performance forecast, although the final amount will be determined after evaluation and audit by qualified assessment and auditing institutions [1]

Jiangsu Canopus Wisdom Medical Technology -东星医疗(301290.SZ):预计2025年净亏损3200万元-4500万元 - Reportify